Jazz Pharmaceuticals (JAZZ) PT Lowered to $200 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Ken Cacciatore lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $200.00 (from $225.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
